Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

CAR-T cell therapy has revolutionized the treatment of relapsed and refractory B-acute lymphoblastic leukemia (B-ALL), with ...

Currently, doctors usually check PSA levels about six to eight weeks after surgery. However, a new study from Mass General ...

From the approval of the first immune checkpoint inhibitors to the development of chimeric antigen receptor T cells, immunotherapy has demonstrated ...

(PDCs) demonstrate tumor-selective delivery and potent anticancer activityPreclinical data show robust efficacy ...

The following is a summary of "Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines," ...

Circulating tumor DNA may be a prognostic biomarker for relapse and early recurrence detection in resected early-stage ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels.